Approval · Notice of Compliance 3136 · 1998
ACCURETIC: Notice of Compliance 3136
Issued March 1, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3136
- Date
- March 1, 1998
- Company
- Parke-Davis Division, Warner-Lambert Canada Inc.Scarborough, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Angiotensin converting enzyme inhibitor/diuretic
Products in this notice
Medicinal ingredients
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- QUINAPRIL HCL 10 MG per TAB
- QUINAPRIL HCL 20 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB